PIANO COVID-19 - Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19
Head :
ROLLAND Yves
Last update : 04/21/2021 | Version : 1 | ID : 73934
| General | |
| Identification | |
| Detailed name | Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19 |
| Sign or acronym | PIANO COVID-19 |
| General Aspects | |
| Medical area |
Geriatrics |
| Study in connection with Covid-19 |
Yes |
| Scientific investigator(s) (Contact) | |
| Name of the director | ROLLAND |
| Surname | Yves |
| Address | Gérontopôle de Toulouse,<br>Cité de la Santé,<br>Place Lange<br>31059 Toulouse <br> |
| Phone | +33 (0)5 61 77 21 00 |
| Organization | GERIATRIC UNIT TOULOUSE UNIVERSITY HOSPITAL |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Funding | |
| Funding status |
Public |
| Details | DGOS (General Directorate of Healthcare Supply) funding |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Toulouse University Hospital |
| Organisation status |
Public |
| Presence of scientific or steering committees |
No |
| Additional contact | |
| Name of the contact | PENNETIER |
| Surname | Delphine |
| Address | Gérontopôle de Toulouse,<br>Cité de la Santé,<br>Place Lange<br>31059 Toulouse |
| Phone | 05 61 77 70 11 |
| pennetier.d@chu-toulouse.fr | |
| Organization | GERIATRIC UNIT - TOULOUSE UNIVERSITY HOSPITAL |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Database objective | |
| Main objective |
The main objective is to compare the occurrence of global death of residents during a 1-year period (from January 2020 to December 2020) in NH and LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH and LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.
The secondary objectives are: - To compare the rate of death related to confirmed or suspected COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU. - To compare the rate of death not related to COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU. - To analyze the incidence of serious health events (deaths, hospitalizations) and the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France during a 12-month (2021) observation period. - To analyze the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France according to the rate of vaccination against COVID among the NH’s/LTCU’s staff during the same observational period. From an economic perspective: - To assess the economic impact of the implementation of prevention measures applied by nursing homes staff, from healthcare system and the NH perspectives, 6, and 12 months before and 6, 12 months to 24 months after the implementation of the preventive measures. - To assess the economic impact of the vaccination among residents and NH’staff, from healthcare system and the NH perspectives, 6 and 12 months before and after the vaccination campaign. These data will also provide indirect economic information about the tolerance of the vaccination. - To assess the efficiency of the high level implementation of the recommendation to prevent and control COVID-19 in comparison with the low level implementation of recommendation to prevent and control COVID-19, using a cost-effectiveness analysis at 12 and 24 months. - To assess the efficiency of the vaccination, at 6 and 12 months, among residents and healthcare professionals in comparison with no vaccination, using a cost-effectiveness analysis |
| Inclusion criteria |
NHs and LTCU volunteers to participate from different region of France (from low impacted to highly impacted region) will be welcomed.
NON-INCLUSION CRITERIA NHs or LTCUs that refuse to participate. |
| Population type | |
| Age |
Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
General population |
| Pathology | |
| Gender |
Male Woman |
| Geography area |
National |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2021 |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individuals |
| Details of the number of individuals | 9,600 persons from 120 nursing homes (coordinating nurses or coordinating physicians). |
| Data | |
| Type of data collected |
Clinical data Cost data |
| Clinical data (detail) |
Direct physical measures |
| Cost data (detail) | healthcare consumption data collected via the health insurance scheme |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/mortality Health care consumption and services |
| Care consumption (detail) |
Hospitalization Medical/paramedical consultation |
| Procedures | |
| Data collection method | Excel file; CRF |
| Participant monitoring |
Yes |
| Details on monitoring of participants | in 2021: vital status, GIR, and COVID vaccination data of participants will be collected |
| Promotion and access | |
| Promotion | |
| Access |
